Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice
- PMID: 34851167
- PMCID: PMC8636109
- DOI: 10.1128/msphere.00851-21
Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice
Abstract
The drug acarbose is used to treat diabetes and, by inhibiting α-amylase in the small intestine, increases the amount of starch entering the lower digestive tract. This results in changes to the composition of the microbiota and their fermentation products. Acarbose also increases longevity in mice, an effect that has been correlated with increased production of the short-chain fatty acids propionate and butyrate. In experiments replicated across three study sites, two distantly related species in the bacterial family Muribaculaceae were dramatically more abundant in acarbose-treated mice, distinguishing these responders from other members of the family. Bacteria in the family Muribaculaceae are predicted to produce propionate as a fermentation end product and are abundant and diverse in the guts of mice, although few isolates are available. We reconstructed genomes from metagenomes (MAGs) for nine populations of Muribaculaceae to examine factors that distinguish species that respond positively to acarbose. We found two closely related MAGs (B1A and B1B) from one responsive species that both contain a polysaccharide utilization locus with a predicted extracellular α-amylase. These genomes also shared a periplasmic neopullulanase with another, distantly related MAG (B2) representative of the only other responsive species. This gene differentiated these three MAGs from MAGs representative of nonresponding species. Differential gene content in B1A and B1B may be associated with the inconsistent response of this species to acarbose across study sites. This work demonstrates the utility of culture-free genomics for inferring the ecological roles of gut bacteria, including their response to pharmaceutical perturbations. IMPORTANCE The drug acarbose is used to treat diabetes by preventing the breakdown of starch in the small intestine, resulting in dramatic changes in the abundance of some members of the gut microbiome and its fermentation products. In mice, several of the bacteria that respond most positively are classified in the family Muribaculaceae, members of which produce propionate as a primary fermentation product. Propionate has been associated with gut health and increased longevity in mice. We found that genomes of the most responsive Muribaculaceae showed signs of specialization for starch fermentation, presumably providing them a competitive advantage in the large intestine of animals consuming acarbose. Comparisons among genomes enhance existing models for the ecological niches occupied by members of this family. In addition, genes encoding one type of enzyme known to participate in starch breakdown were found in all three genomes from responding species but none of the other genomes.
Keywords: competition; gut microbiome; longevity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice.BMC Microbiol. 2019 Jun 13;19(1):130. doi: 10.1186/s12866-019-1494-7. BMC Microbiol. 2019. PMID: 31195972 Free PMC article.
-
The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome.mSphere. 2019 Feb 6;4(1):e00528-18. doi: 10.1128/mSphere.00528-18. mSphere. 2019. PMID: 30728281 Free PMC article.
-
Metagenome-Assembled Genomes Contribute to Unraveling of the Microbiome of Cocoa Fermentation.Appl Environ Microbiol. 2021 Jul 27;87(16):e0058421. doi: 10.1128/AEM.00584-21. Epub 2021 Jul 27. Appl Environ Microbiol. 2021. PMID: 34105982 Free PMC article.
-
Exploration of the Muribaculaceae Family in the Gut Microbiota: Diversity, Metabolism, and Function.Nutrients. 2024 Aug 12;16(16):2660. doi: 10.3390/nu16162660. Nutrients. 2024. PMID: 39203797 Free PMC article. Review.
-
Starch Digestion by Gut Bacteria: Crowdsourcing for Carbs.Trends Microbiol. 2020 Feb;28(2):95-108. doi: 10.1016/j.tim.2019.09.004. Epub 2019 Oct 14. Trends Microbiol. 2020. PMID: 31624005 Review.
Cited by
-
Tributyrin and anise mixture supplementation improves growth performance, nutrient digestibility, jejunal villus height, and fecal microbiota in weaned pigs.Front Vet Sci. 2023 Jan 27;10:1107149. doi: 10.3389/fvets.2023.1107149. eCollection 2023. Front Vet Sci. 2023. PMID: 36777676 Free PMC article.
-
Avenanthramide Improves Colonic Damage Induced by Food Allergies in Mice through Altering Gut Microbiota and Regulating Hsp70-NF-κB Signaling.Nutrients. 2023 Feb 16;15(4):992. doi: 10.3390/nu15040992. Nutrients. 2023. PMID: 36839351 Free PMC article.
-
OLED catheters for inner-body phototherapy: A case of type 2 diabetes mellitus improved via duodenal photobiomodulation.Sci Adv. 2023 Sep;9(35):eadh8619. doi: 10.1126/sciadv.adh8619. Epub 2023 Sep 1. Sci Adv. 2023. PMID: 37656783 Free PMC article.
-
Boosting HSA Vaccination with Jujube Powder Modulating Gut Microbiota Favorable for Arginine Metabolism.Nutrients. 2023 Apr 19;15(8):1955. doi: 10.3390/nu15081955. Nutrients. 2023. PMID: 37111173 Free PMC article.
-
Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.J Diabetes. 2023 Feb;15(2):165-180. doi: 10.1111/1753-0407.13356. Epub 2023 Jan 22. J Diabetes. 2023. PMID: 36682739 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials